EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome
Glenn E. Palomaki(Brown University), Monica R. McClain(Women & Infants Hospital of Rhode Island), Stephanie Melillo(Centers for Disease Control and Prevention), Heather L. Hampel(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Stephen N. Thibodeau(Mayo Clinic)
Cited by 468Open Access
Abstract
An original evidence review examined screening and diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) and the subsequent outcomes in a population of newly diagnosed cases of colorectal cancer (CRC). This supplementary evidence review focuses on five issues of further interest to the Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group (EWG), as summarized below.
Related Papers
No related papers found
Powered by citation graph analysis